Pepstatin
AlkaPlorer ID: AK021612
Synonym: 'Ahpatinin C', 'Pepsin inhibitor S 735A', 'Procidin S 735A', 'NSC 272671', 'Pepstatin A', 'Pepstatin'
IUPAC Name: (3S,4S)-3-hydroxy-4-[[(2S)-2-[[(3S,4S)-3-hydroxy-6-methyl-4-[[(2S)-3-methyl-2-[[(2S)-3-methyl-2-(3-methylbutanoylamino)butanoyl]amino]butanoyl]amino]heptanoyl]amino]propanoyl]amino]-6-methylheptanoic acid
Structure
SMILES: CC(C)CC(O)=N[C@H](C(O)=N[C@H](C(O)=N[C@@H](CC(C)C)[C@@H](O)CC(O)=N[C@@H](C)C(O)=N[C@@H](CC(C)C)[C@@H](O)CC(=O)O)C(C)C)C(C)C
InChI: InChI=1S/C34H63N5O9/c1-17(2)12-23(37-33(47)31(21(9)10)39-34(48)30(20(7)8)38-27(42)14-19(5)6)25(40)15-28(43)35-22(11)32(46)36-24(13-18(3)4)26(41)16-29(44)45/h17-26,30-31,40-41H,12-16H2,1-11H3,(H,35,43)(H,36,46)(H,37,47)(H,38,42)(H,39,48)(H,44,45)/t22-,23-,24-,25-,26-,30-,31-/m0/s1
InChIKey: FAXGPCHRFPCXOO-LXTPJMTPSA-N
Reference
Antiangiogenic potentials of ahpatinins obtained from a Streptomyces species
PubChem CID: 5478883
CAS: 26305-03-3
LOTUS: LTS0169498
NPASS: NPC478715
Source
| Species | Genus | Family | Order | Class | Phylum | Kingdom | Domain |
|---|---|---|---|---|---|---|---|
| Nauclea orientalis | Nauclea | Rubiaceae | Gentianales | Magnoliopsida | Streptophyta | Viridiplantae | Eukaryota |
| Guatteria multivenia | Guatteria | Annonaceae | Magnoliales | Magnoliopsida | Streptophyta | Viridiplantae | Eukaryota |
Properties Information
Molecule Weight: 685.9040000000002
TPSA?: 240.71
MolLogP?: 5.668700000000005
Number of H-Donors: 8
Number of H-Acceptors: 8
RingCount: 0
Activities Information
| Organism | Target Name | Standard Type | Standard Value | Standard Units | doi |
|---|---|---|---|---|---|
| Bos taurus | Cathepsin D | IC50 | 10.0 | nM | 10.1021/jm00172a005 |
| Bos taurus | Cathepsin D | IC50 | 28.0 | nM | 10.1021/jm00149a001 |
| Bos taurus | Cathepsin D | IC50 | 28.0 | nM | 10.1021/jm00160a048 |
| Bos taurus | Cathepsin D | IC50 | 28.0 | nM | 10.1021/jm00160a049 |
| Bos taurus | Cathepsin D | Ki | 0.5 | nM | 10.1021/jm00162a015 |
| Candida albicans | Candida albicans | Activity | 0.0 | 10'3CFU/ml | 10.1021/jm901734u |
| Candida albicans | Candida albicans | Activity | 3.8 | 10'3CFU/ml | 10.1021/jm901734u |
| Candida albicans | Candida albicans | Activity | 5.0 | 10'3CFU/ml | 10.1021/jm901734u |
| Candida albicans | Candida albicans | Activity | 9.4 | 10'3CFU/ml | 10.1021/jm901734u |
| Candida albicans | Candida albicans | Activity | 19.8 | 10'3CFU/ml | 10.1021/jm901734u |
| Candida albicans | Candida albicans | Activity | 28.0 | 10'3CFU/ml | 10.1021/jm901734u |
| Candida albicans | Candida albicans | Activity | 30.0 | 10'3CFU/ml | 10.1021/jm901734u |
| Candida albicans | Candida albicans | Activity | 32.4 | 10'3CFU/ml | 10.1021/jm901734u |
| Candida albicans | Candida albicans | Activity | 37.2 | 10'3CFU/ml | 10.1021/jm901734u |
| Candida albicans | Candida albicans | Activity | 51.0 | 10'3CFU/ml | 10.1021/jm901734u |
| Candida albicans | Candida albicans | Activity | 52.0 | 10'3CFU/ml | 10.1021/jm901734u |
| Candida albicans | Candida albicans | Activity | 56.8 | 10'3CFU/ml | 10.1021/jm901734u |
| Candida albicans | Candida albicans | Activity | 58.4 | 10'3CFU/ml | 10.1021/jm901734u |
| Candida albicans | Candida albicans | Activity | 100.0 | 10'3CFU/ml | 10.1021/jm901734u |
| Candida albicans | Candidapepsin-1 | Activity | nan | None | 10.1128/aac.01072-07 |
| Candida albicans | Candidapepsin-2 | Activity | nan | None | 10.1128/aac.01072-07 |
| Candida albicans | Candidapepsin-2 | IC50 | 90.0 | nM | 10.1016/j.bmc.2012.09.031 |
| Candida albicans | Candidapepsin-3 | Activity | nan | None | 10.1128/aac.01072-07 |
| Candida albicans | Candidapepsin-6 | Activity | nan | None | 10.1128/aac.01072-07 |
| Candida albicans | Candidapepsin-8 | Activity | nan | None | 10.1128/aac.01072-07 |
| Candida albicans | Candidapepsin-9 | Activity | nan | None | 10.1128/aac.01072-07 |
| Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast) | Candidapepsin-5 | Activity | nan | None | 10.1128/aac.01072-07 |
| Candida albicans (strain WO-1) (Yeast) | Candidapepsin-4 | Activity | nan | None | 10.1128/aac.01072-07 |
| Chlorocebus sabaeus | Vero C1008 | AUC cytotoxicity | 262.3 | None | 10.1038/s41586-020-2286-9 |
| Chlorocebus sabaeus | Vero C1008 | pCC50 | 7.71 | None | 10.1038/s41586-020-2286-9 |
| Hepatitis C virus genotype 1a (isolate H) (HCV) | Genome polyprotein | IC50 | 500.0 | nM | None |
| Homo sapiens | ADAM9 | IC50 | 56.3 | nM | 10.1021/jm9009394 |
| Homo sapiens | ATP-dependent DNA helicase Q1 | Potency | 31622.8 | nM | None |
| Homo sapiens | Beta-secretase 1 | Activity | nan | None | 10.1016/j.bmcl.2003.11.061 |
| Homo sapiens | Cathepsin B | IC50 | 4260.0 | nM | 10.1021/jm8014734 |
| Homo sapiens | Cathepsin D | Activity | 34.0 | % | 10.1021/acs.jnatprod.7b00551 |
| Homo sapiens | Cathepsin D | Activity | 36.0 | % | 10.1021/acs.jnatprod.7b00551 |
| Homo sapiens | Cathepsin D | IC50 | 0.0016 | ug.mL-1 | 10.1007/s00044-012-0397-z |
| Homo sapiens | Cathepsin D | IC50 | 0.05 | nM | 10.1021/acs.jnatprod.8b00417 |
| Homo sapiens | Cathepsin D | IC50 | 0.1 | nM | 10.1021/acs.jnatprod.7b00551 |
| Homo sapiens | Cathepsin D | IC50 | 0.173 | nM | 10.1021/jm9009394 |
| Homo sapiens | Cathepsin D | IC50 | 0.35 | nM | 10.1016/j.bmc.2016.04.062 |
| Homo sapiens | Cathepsin D | IC50 | 0.35 | nM | 10.1021/acs.jnatprod.7b00551 |
| Homo sapiens | Cathepsin D | IC50 | 0.49 | nM | 10.1021/acs.jmedchem.9b01351 |
| Homo sapiens | Cathepsin D | IC50 | 0.55 | nM | 10.1016/j.bmcl.2008.02.060 |
| Homo sapiens | Cathepsin D | IC50 | 0.693 | nM | 10.1016/j.bmc.2022.116646 |
| Homo sapiens | Cathepsin D | IC50 | 0.693 | nM | 10.1021/jm301630s |
| Homo sapiens | Cathepsin D | IC50 | 1.0 | nM | 10.1016/j.bmc.2020.115879 |
| Homo sapiens | Cathepsin D | IC50 | 1.0 | nM | 10.1016/j.bmcl.2014.07.054 |
| Homo sapiens | Cathepsin D | IC50 | 2.0 | nM | 10.1016/s0960-894x(99)00433-3 |
| Homo sapiens | Cathepsin D | IC50 | 2.3 | nM | 10.1016/j.bmcl.2006.06.010 |
| Homo sapiens | Cathepsin D | IC50 | 5.0 | nM | 10.1021/jm9009394 |
| Homo sapiens | Cathepsin D | IC50 | 100.0 | nM | 10.1021/acs.jnatprod.7b00551 |
| Homo sapiens | Cathepsin D | IC50 | 1000.0 | nM | 10.1021/acs.jnatprod.7b00551 |
| Homo sapiens | Cathepsin D | IC50 | 5000.0 | nM | 10.1021/jm9009394 |
| Homo sapiens | Cathepsin D | IC50 | 100000.0 | nM | 10.1021/jm8014734 |
| Homo sapiens | Cathepsin D | INH | 0.1 | nM | 10.1016/j.bmc.2022.117043 |
| Homo sapiens | Cathepsin D | Inhibition | 50.0 | % | 10.1021/acs.jnatprod.7b00551 |
| Homo sapiens | Cathepsin D | Inhibition | 98.7 | % | 10.1016/j.bmc.2020.115879 |
| Homo sapiens | Cathepsin D | Inhibition | 99.71 | % | 10.1016/j.ejmech.2022.114851 |
| Homo sapiens | Cathepsin D | Inhibition | nan | % | 10.1021/acs.jnatprod.7b00551 |
| Homo sapiens | Cathepsin D | Ki | 0.01 | nM | 10.1021/jm990412m |
| Homo sapiens | Cathepsin D | Log Kd | -11.43 | None | 10.1021/jm0105833 |
| Homo sapiens | Cathepsin D | Ratio IC50 | 20.0 | None | 10.1021/jm9009394 |
| Homo sapiens | Cathepsin D | Ratio IC50 | 1000.0 | None | 10.1021/jm9009394 |
| Homo sapiens | Cathepsin D | Ratio IC50 | 29000.0 | None | 10.1021/jm9009394 |
| Homo sapiens | Cathepsin E | IC50 | 0.08 | nM | 10.1016/j.bmc.2016.04.062 |
| Homo sapiens | Cathepsin E | IC50 | 0.1 | nM | 10.1021/acs.jnatprod.7b00551 |
| Homo sapiens | Cathepsin E | IC50 | 0.181 | nM | 10.1021/jm9009394 |
| Homo sapiens | Cathepsin E | IC50 | 0.3 | nM | 10.1021/acs.jnatprod.7b00551 |
| Homo sapiens | Cathepsin E | IC50 | 0.446 | nM | 10.1016/j.bmc.2022.116646 |
| Homo sapiens | Cathepsin E | IC50 | 0.446 | nM | 10.1021/jm301630s |
| Homo sapiens | Cathepsin E | IC50 | 5.0 | nM | 10.1021/jm9009394 |
| Homo sapiens | Cathepsin E | IC50 | 7.5 | nM | 10.1016/j.bmcl.2014.07.054 |
| Homo sapiens | Cathepsin E | IC50 | 100.0 | nM | 10.1021/acs.jnatprod.7b00551 |
| Homo sapiens | Cathepsin E | IC50 | 1000.0 | nM | 10.1021/acs.jnatprod.7b00551 |
| Homo sapiens | Cathepsin E | IC50 | 5000.0 | nM | 10.1021/jm9009394 |
| Homo sapiens | Cathepsin E | Ratio IC50 | 20.0 | None | 10.1021/jm9009394 |
| Homo sapiens | Cathepsin E | Ratio IC50 | 1000.0 | None | 10.1021/jm9009394 |
| Homo sapiens | Cathepsin E | Ratio IC50 | 29000.0 | None | 10.1021/jm9009394 |
| Homo sapiens | Cathepsin H | IC50 | 100000.0 | nM | 10.1021/jm8014734 |
| Homo sapiens | Cathepsin L | IC50 | 800.0 | nM | 10.1021/jm8014734 |
| Homo sapiens | Cathepsin L | Inhibition | nan | % | 10.1016/j.ejmech.2022.114851 |
| Homo sapiens | Chymotrypsin C | IC50 | 100000.0 | nM | 10.1021/jm00172a005 |
| Homo sapiens | Geminin | Potency | 517.4 | nM | None |
| Homo sapiens | Histone acetyltransferase GCN5 | Potency | 17782.8 | nM | None |
| Homo sapiens | Histone acetyltransferase GCN5 | Potency | 39810.7 | nM | None |
| Homo sapiens | Histone deacetylase 6 | Inhibition | -5.61 | % | 10.6019/CHEMBL4808148 |
| Homo sapiens | Histone deacetylase 6 | Inhibition | 0.56 | % | 10.6019/CHEMBL4808148 |
| Homo sapiens | Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 | Potency | 251.2 | nM | None |
| Homo sapiens | MDA-MB-231 | Activity | 48.0 | % | 10.1021/acs.jnatprod.7b00551 |
| Homo sapiens | MDA-MB-231 | Activity | nan | None | 10.1021/acs.jnatprod.7b00551 |
| Homo sapiens | MDA-MB-231 | IC50 | nan | None | 10.1007/s00044-012-0397-z |
| Homo sapiens | NHDF | Activity | nan | None | 10.1021/acs.jmedchem.9b01351 |
| Homo sapiens | Parathyroid hormone receptor | Potency | 125892.5 | nM | None |
| Homo sapiens | PBMC | Activity | nan | None | 10.1021/acs.jmedchem.9b01351 |
| Homo sapiens | Pepsin A | IC50 | 59.0 | nM | 10.1021/jm980015w |
| Homo sapiens | Regulator of G-protein signaling 4 | Potency | 5972.8 | nM | None |
| Homo sapiens | Renin | IC50 | 1300.0 | nM | 10.1021/jm00150a007 |
| Homo sapiens | Renin | IC50 | 1400.0 | nM | 10.1021/jm00157a006 |
| Homo sapiens | Renin | IC50 | 2000.0 | nM | 10.1021/jm00157a006 |
| Homo sapiens | Renin | IC50 | 3200.0 | nM | 10.1021/jm00126a038 |
| Homo sapiens | Renin | IC50 | 3200.0 | nM | 10.1021/jm00390a018 |
| Homo sapiens | Renin | IC50 | 6000.0 | nM | 10.1021/jm00149a001 |
| Homo sapiens | Renin | IC50 | 6000.0 | nM | 10.1021/jm00160a048 |
| Homo sapiens | Renin | IC50 | 6000.0 | nM | 10.1021/jm00160a049 |
| Homo sapiens | Renin | IC50 | 14000.0 | nM | 10.1021/jm00157a006 |
| Homo sapiens | Renin | IC50 | 15000.0 | nM | 10.1021/jm00157a006 |
| Homo sapiens | Renin | IC50 | 22000.0 | nM | 10.1021/jm00150a007 |
| Homo sapiens | Renin | IC50 | 22000.0 | nM | 10.1021/jm00381a001 |
| Homo sapiens | Renin | IC50 | 22000.0 | nM | 10.1021/jm00396a006 |
| Homo sapiens | Renin | IC50 | 29300.0 | nM | 10.1021/jm00171a033 |
| Homo sapiens | Renin | IC50 | 41000.0 | nM | 10.1021/jm00126a038 |
| Homo sapiens | Renin | IC50 | 92000.0 | nM | 10.1021/jm00172a005 |
| Homo sapiens | Renin | Ki | 100.0 | nM | 10.1021/jm00136a001 |
| Homo sapiens | Renin | Ki | 13000.0 | nM | 10.1021/jm00150a007 |
| Homo sapiens | TAR DNA-binding protein 43 | Potency | 354.8 | nM | None |
| Homo sapiens | Tyrosyl-DNA phosphodiesterase 1 | Potency | 79432.8 | nM | None |
| Homo sapiens | Vitamin D receptor | Potency | 89125.1 | nM | None |
| Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | EC50 | 51800.0 | nM | 10.1021/np0003995 |
| Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | EC50 | 69000.0 | nM | 10.1021/np0003995 |
| Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | EC50 | 150000.0 | nM | 10.1021/np0003995 |
| Human immunodeficiency virus 1 | Human immunodeficiency virus type 1 protease | Inhibition | 23.0 | % | 10.1016/j.bmcl.2004.09.034 |
| Human immunodeficiency virus 1 | Human immunodeficiency virus type 1 protease | Ki | 16.98 | nM | 10.1021/jm00038a006 |
| Human immunodeficiency virus 1 | Human immunodeficiency virus type 1 protease | Ki | 230.0 | nM | 10.1021/jm5008352 |
| Human immunodeficiency virus 1 | Human immunodeficiency virus type 1 protease | Ki | 1400.0 | nM | 10.1021/jm00112a001 |
| Human immunodeficiency virus 1 | Human immunodeficiency virus type 1 protease | Ki | 3100.0 | nM | 10.1021/jm00041a005 |
| Human immunodeficiency virus 1 | Protease | IC50 | 0.001 | ug.mL-1 | 10.1021/np8001139 |
| Human immunodeficiency virus 1 | Protease | IC50 | 41.0 | nM | 10.1016/j.bmc.2009.03.059 |
| Human immunodeficiency virus 1 | Protease | IC50 | 1300.0 | nM | 10.1016/j.bmc.2009.03.019 |
| Human immunodeficiency virus 1 | Protease | IC50 | 1500.0 | nM | 10.1021/jm701575k |
| Human immunodeficiency virus 1 | Protease | Inhibition | 56.0 | % | 10.1016/j.ejmech.2014.07.049 |
| Human immunodeficiency virus 1 | Protease | Inhibition | 74.0 | % | 10.1016/j.ejmech.2014.07.049 |
| Human immunodeficiency virus 1 | Protease | Inhibition | nan | % | 10.1016/j.ejmech.2015.06.054 |
| Human immunodeficiency virus 1 | Protease | Ki | 36.0 | nM | 10.1016/j.bmc.2013.06.018 |
| Human immunodeficiency virus 1 | Protease | Ki | 38.0 | nM | 10.1016/j.bmc.2009.03.059 |
| Human immunodeficiency virus 1 | Protease | Ki | 50.0 | nM | 10.1016/j.bmc.2009.03.059 |
| Human immunodeficiency virus 1 | Protease | Ki | 51.0 | nM | 10.1016/j.bmc.2013.06.018 |
| Human immunodeficiency virus 1 | Protease | Ki | 52.0 | nM | 10.1016/j.bmc.2013.06.018 |
| Human immunodeficiency virus 1 | Protease | Ki | 94.0 | nM | 10.1021/jm5008352 |
| Human immunodeficiency virus 1 | Protease | Ki | 1100.0 | nM | 10.1021/np0003995 |
| Human T-cell leukemia virus 1 (strain Japan ATK-1 subtype A) (HTLV-1) | Human T-cell leukemia virus type I protease | Inhibition | 15.0 | % | 10.1016/j.bmcl.2004.09.034 |
| Human T-cell leukemia virus 1 (strain Japan ATK-1 subtype A) (HTLV-1) | Human T-cell leukemia virus type I protease | Inhibition | 17.0 | % | 10.1016/j.bmcl.2004.09.034 |
| Human T-cell leukemia virus 1 (strain Japan ATK-1 subtype A) (HTLV-1) | Human T-cell leukemia virus type I protease | Ki | 14600.0 | nM | 10.1016/j.bmcl.2004.09.034 |
| Human T-cell leukemia virus 1 (strain Japan ATK-1 subtype A) (HTLV-1) | Human T-cell leukemia virus type I protease | Ki | 36500.0 | nM | 10.1016/j.bmcl.2004.09.034 |
| Leishmania donovani | Cysteine protease | IC50 | 160.0 | nM | 10.1021/jm0493717 |
| Mus musculus | Mus musculus | Inhibition | 91.91 | % | 10.1021/jm058208o |
| Oryctolagus cuniculus | Angiotensin-converting enzyme | IC50 | 100000.0 | nM | 10.1021/jm00172a005 |
| Plasmodium berghei | Plasmodium berghei | Inhibition | 92.94 | % | 10.1016/j.bmc.2008.02.011 |
| Plasmodium berghei | Plasmodium berghei | Inhibition | 92.94 | % | 10.1016/j.ejmech.2008.08.005 |
| Plasmodium berghei | Plasmodium berghei | Inhibition | 95.45 | % | 10.1016/j.bmc.2011.01.050 |
| Plasmodium falciparum | Plasmepsin 1 | IC50 | 0.9 | nM | 10.1016/j.bmc.2018.04.012 |
| Plasmodium falciparum | Plasmepsin 2 | Activity | 85.2 | % | 10.1021/jm100233b |
| Plasmodium falciparum | Plasmepsin 2 | IC50 | 0.42 | nM | 10.1016/j.bmc.2018.04.012 |
| Plasmodium falciparum | Plasmepsin 2 | IC50 | 0.68 | nM | 10.1016/j.bmcl.2008.02.060 |
| Plasmodium falciparum | Plasmepsin 2 | Inhibition | 82.8 | % | 10.1021/jm100233b |
| Plasmodium falciparum | Plasmepsin 2 | Inhibition | 97.8 | % | 10.1021/jm100233b |
| Plasmodium falciparum | Plasmepsin 4 | IC50 | 0.3 | nM | 10.1016/j.bmc.2018.04.012 |
| Plasmodium falciparum | Plasmodium falciparum | Activity | 93.77 | % | 10.1016/j.ejmech.2008.09.044 |
| Plasmodium falciparum | Plasmodium falciparum | Activity | nan | None | 10.1128/aac.00840-06 |
| Plasmodium falciparum | Plasmodium falciparum | EC50 | 14000.0 | nM | 10.1128/aac.00840-06 |
| Plasmodium falciparum | Plasmodium falciparum | EC50 | nan | None | 10.1128/aac.00840-06 |
| Plasmodium falciparum | Plasmodium falciparum | IC50 | 29360.0 | nM | 10.1128/aac.00057-08 |
| Plasmodium falciparum | Plasmodium falciparum | IC50 | 39200.0 | nM | 10.1128/aac.00057-08 |
| Plasmodium falciparum | Plasmodium falciparum | Potency | 5858.4 | nM | None |
| Plasmodium falciparum | Plasmodium falciparum | Potency | 9285.0 | nM | None |
| Rattus norvegicus | Renin | IC50 | 1000.0 | nM | 10.1021/jm00157a006 |
| Rattus norvegicus | Renin | IC50 | 8300.0 | nM | 10.1021/jm00157a006 |
| Rattus norvegicus | Renin | IC50 | 13000.0 | nM | 10.1021/jm00396a006 |
| Severe acute respiratory syndrome coronavirus 2 | Replicase polyprotein 1ab | Inhibition | 9.112 | % | 10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 | Replicase polyprotein 1ab | Inhibition | 13.53 | % | 10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | AUC | 313.0 | None | 10.1038/s41586-020-2286-9 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | IC50 | 776.25 | nM | 10.1038/s41586-020-2286-9 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | IC50 | 19952.62 | nM | 10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | IC50 | 20000.0 | nM | 10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | Inhibition | -0.04 | % | 10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | Inhibition | 0.02 | % | 10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | Inhibition | 49.0 | % | 10.21203/rs.3.rs-23951/v1 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | Inhibition index | -0.009251 | None | 10.1101/2020.04.03.023846 |
| Sus scrofa | Pepsin A | IC50 | 7.0 | nM | 10.1021/jm00111a054 |
| Sus scrofa | Pepsin A | IC50 | 10.0 | nM | 10.1021/jm00149a001 |
| Sus scrofa | Pepsin A | IC50 | 10.0 | nM | 10.1021/jm00160a048 |
| Sus scrofa | Pepsin A | IC50 | 10.0 | nM | 10.1021/jm00160a049 |
| Sus scrofa | Pepsin A | IC50 | 18.0 | nM | 10.1021/jm00172a005 |
| Sus scrofa | Pepsin A | Ki | 4.6e-08 | nM | 10.1021/jm00111a054 |
| Sus scrofa | Pepsin A | Ki | 0.056 | nM | 10.1021/jm00381a001 |
| Trypanosoma brucei | 6-phospho-1-fructokinase | Potency | 5358.2 | nM | None |
| Trypanosoma cruzi | Cruzipain | Potency | 31622.8 | nM | None |
| None | ADMET | AUC Ratio | 0.838 | None | 10.1038/s41586-020-2286-9 |
| None | ADMET | Inhibition | 91.91 | % | 10.1016/j.ejmech.2007.01.001 |
| None | ADMET | Papp | 1.1 | 10'-7 cm/s | 10.1021/acs.jmedchem.9b01351 |
| None | ADMET | TI | 1.4 | None | 10.1021/np0003995 |
| None | No relevant target | Solubility | 197.0 | ug.mL-1 | 10.1021/acs.jmedchem.9b01351 |
| None | Unchecked | Activity | nan | None | 10.1074/jbc.m703643200 |
| None | Unchecked | IC50 | 0.0015 | ug.mL-1 | 10.1021/np0200616 |
| None | Unchecked | IC50 | 0.006 | ug.mL-1 | 10.1021/np010042g |
| None | Unchecked | IC50 | 0.006 | ug.mL-1 | 10.1021/np0200717 |
| None | Unchecked | IC50 | 0.1 | nM | 10.1016/j.bmcl.2014.07.054 |
| None | Unchecked | IC50 | 3.0 | nM | 10.1021/np8002707 |
| None | Unchecked | IC50 | 16.0 | nM | 10.1021/np010172p |
| None | Unchecked | IC50 | 22.0 | nM | 10.1016/j.ejmech.2020.112515 |
| None | Unchecked | IC50 | 31.0 | nM | 10.1021/jm9807306 |
| None | Unchecked | IC50 | 310.0 | nM | 10.1021/np010172p |
| None | Unchecked | IC50 | nan | None | 10.1016/j.bmc.2009.03.019 |
| None | Unchecked | ID50 | 0.0052 | ug ml-1 | 10.1021/jm00191a023 |
| None | Unchecked | ID50 | 2.0 | ug ml-1 | 10.1021/jm00191a023 |
| None | Unchecked | Inhibition | 100.0 | % | 10.1016/j.ejmech.2020.112515 |
| None | Unchecked | Ki | 0.15 | nM | 10.1021/jm00381a001 |
| None | Unchecked | Potency | 22387.2 | nM | None |
| None | Unchecked | Ratio IC50 | 1.1 | None | 10.1021/acs.jnatprod.7b00551 |
| None | Unchecked | Ratio IC50 | 4.4 | None | 10.1016/j.bmc.2016.04.062 |
| None | Unchecked | Ratio Ki | 2.5 | None | 10.1021/jm5008352 |
